RNAZ
TransCode Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 20, 2026 3:30:03 PM EDT
1.67USD-1.765%(-0.03)19,929
RNAZ Financials
In Q2 FY 2026 (ended ), TransCode Therapeutics, Inc. Common Stock (RNAZ) reported net income of −$6.75M, operating cash flow of −$5.4M, and assets of $151.01M.
Loading financial flows…